Table 2. Studies for the use of non-fasting TG and remnant cholesterol levels as predictors of CVD events.

	Primary endpoint	Sample size	Primary endpoint Hazard ratio (95% CI)
Varbo et al.16)	Incidence of CVD with 88.41 mg/dL increase in non-fasting remnant cholesterol	73513	1.4 (1.3-1.5)
Nordestgaard et al.27)	Incident MI, CVD, and death with 88.41 mg/dL increase in non-fasting TG	13981	Men 1.14 (1.10-1.19) Women 1.30 (1.22-1.40)
The Women's Health Study28)	Incident CVD, non-fatal MI, non-fatal stroke, coronary revascularization or cardiovascular death	26509	2.53 (1.69-3.79)
Jørgensen et al.30)	Incidence of MI with genetically elevated doubling of non-fasting TG and remnant cholesterol	10391	1.87 (1.25-2.81)

TG: triglyceride, CVD: cardiovascular disease, CI: confidence interval, MI: myocardial infarction